Pyridinone derivertives having inhibition activity on hsp90
KR20100061403A
Contact lenses solution for removing microorganism and acanthamoebae
KR20100126059A
Pharmaceutical composition comprising docetaxel
WO2010114185A1
Method for preparing dendritic cells with capacity to induce cancer-specific immune response, and pharmaceutical composition and kit incorporating dendritic cells for preventing or treating cancer or inhibiting metastasis
KR20100109099A
Method for preparing dendritic cells having potential to induce cancer specific immune response, pharmaceutical composition and kit for treating or preventing cancer or inhibiting cancer metastasis comprising the same
KR20100108028A
IFN-α FUSION PROTEIN COMPRISING INTERFERON-α AND CYTOPLASMIC TRANSDUCTION PEPTIDE
WO2010110503A1
INTERFERON-α (IFN-α) FUSED PROTEIN HAVING IFN-α AND CYTOPLASMIC TRANSDUCTION PEPTIDE (CTP)
KR20100044631A
Method for the stereoselective preparation of beta-methyl vinyl phosphate carbapenem
KR20090107262A
Complex formulation comprising metformin and mitiglinide, and method for preparation thereof
KR20090100969A
Composition for cleaning contact lenses and method for preparing thereof
KR20090014081A
Composition for manufacturing orally disintegrating dosage forms, for protecting the coating of active substance
KR20090090467A
Pharmaceutical composition for improving dissolution rate of cefdinir
KR20090067809A
A solid formulation for dialysis and a method for processing thereof
